Quantedge Capital Pte Ltd - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Quantedge Capital Pte Ltd ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,732,437
-64.7%
179,900
-61.1%
0.94%
-56.8%
Q2 2023$4,914,616
-13.7%
461,900
-14.7%
2.19%
-1.7%
Q1 2023$5,693,424
+31.0%
541,200
+54.3%
2.22%
+52.6%
Q4 2022$4,345,173
+38.4%
350,700
+15.7%
1.46%
+50.5%
Q3 2022$3,139,000
+51.0%
303,000
+68.1%
0.97%
+131.0%
Q2 2022$2,079,000180,3000.42%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders